학술논문
Real-world outcomes with durvalumab after chemoradiotherapy in patients with unresectable stage III NSCLC: interim analysis of overall survival from PACIFIC-R
Document Type
Article
Author
Filippi, A.R.; Bar, J.; Chouaid, C.; Christoph, D.C.; Field, J.K.; Fietkau, R.; Garassino, M.C.; Garrido, P.; Haakensen, V.D.; Kao, S.; Markman, B.; McDonald, F.; Mornex, F.; Moskovitz, M.; Peters, S.; Sibille, A.; Siva, S.; van den Heuvel, M.; Vercauter, P.; Anand, S.; Chander, P.; Licour, M.; de Lima, A.R.; Qiao, Y.; Girard, N.
Source
In ESMO Open June 2024 9(6)
Subject
Language
ISSN
2059-7029